Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hanley

Showing results (421-430 of 436) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Contemporary Clinical Trials|May 5, 2026
Conducting multicenter trials through the trial innovation network comprehensive consultationDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Journal of Clinical and Translational Science|July 30, 2025
Insights from the trial innovation network's initial consultation processPaul A Harris, Nan Kennedy, Consuelo H Wilkins, et al.
JAMA|July 1, 2026
Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical TrialJena L Miller, Ahmet A Baschat, Anthony Johnson, et al.
JAMA Network Open|May 29, 2025
Enhancing Multicenter Trials With the Trial Innovation Network's Initial Consultation ProcessPaul A Harris, Consuelo H Wilkins, Karen Lane, et al.
Stroke|May 6, 2022
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-AnalysisJoji B Kuramatsu, Stefan T Gerner, Wendy Ziai, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Frontiers in Aging Neuroscience|February 15, 2021
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular DiseasesJohannes Boltze, Jaroslaw A Aronowski, Jerome Badaut, et al.
Neurocritical Care|July 8, 2021
Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of ConsciousnessJan Claassen, Yama Akbari, Sheila Alexander, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Pageof 44

Showing results (421-430 of 436) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Contemporary Clinical Trials|May 5, 2026
Conducting multicenter trials through the trial innovation network comprehensive consultationDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Journal of Clinical and Translational Science|July 30, 2025
Insights from the trial innovation network's initial consultation processPaul A Harris, Nan Kennedy, Consuelo H Wilkins, et al.
JAMA|July 1, 2026
Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical TrialJena L Miller, Ahmet A Baschat, Anthony Johnson, et al.
JAMA Network Open|May 29, 2025
Enhancing Multicenter Trials With the Trial Innovation Network's Initial Consultation ProcessPaul A Harris, Consuelo H Wilkins, Karen Lane, et al.
Stroke|May 6, 2022
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-AnalysisJoji B Kuramatsu, Stefan T Gerner, Wendy Ziai, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Frontiers in Aging Neuroscience|February 15, 2021
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular DiseasesJohannes Boltze, Jaroslaw A Aronowski, Jerome Badaut, et al.
Neurocritical Care|July 8, 2021
Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of ConsciousnessJan Claassen, Yama Akbari, Sheila Alexander, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Pageof 44